Mark
Booth
Chief Commercialization Office, Orexigen Therapeutics, Inc.
Richard
Brewer
President and CEO, Arca Discovery Inc.
G.
Steven Burrill
CEO, President and Chairman, Burrill
& Co.
Ted
Davis
VP, Business development, Wright Medical Technology
Chris
Ehrlich
Venture Partner, Interwest
Partners
David
Flores
President and CEO, BioCentury
Paul
Fonteyne
Executive Vice President, Boehringer
Ingelheim
Marc-Henri
Galletti
Managing Director, Longitude Capital
Bill
Gantz
President, Lundbeck Inc.
Winton
Gibbons
SVP, Business Development, Nanosphere
Inc.
Misty
Gruber
Attorney, Dykema Gossett PLLC
Elliott
Hillback, Jr.
Senior Vice President, Corporate Affairs, Genzyme
Corp.
Arthur
Holden
Chairman, Pharmaceutical Biomedical Research Consortium, Ltd.
Barry
Labinger
COO, Human Genome Sciences,
Inc.
John Larson
General Manager, Abbott Neuroscience
Bruno
Larvol
President and CEO, The Larvol Group, Inc.
Scott
Minick
Partner, ARCH
Venture Partners
Arthur Pancoe
Senior Managing Director, Morgan Stanley & Co.
H.
Stewart Parker
CEO, Targeted
Genetics
Norbert
Riedel
Corp. Vice President & CSO, Baxter
Healthcare Corp.
Spiro
Rombotis
CEO, Cyclacel
Pharmaceuticals Limited
Steven
Slaughter
SVP, Business Initiatives, Elan Pharmaceuticals
Lydia
Villa-Komaroff
CEO, Cytonome, Inc.
Scott
Ward
SVP & President,Cardiovascular Business, Medtronic
